Hitachi, Tohoku University and Kyoto University Become World's First to Establish Technology for Highly Efficient, High-quality Production of Actinium-225, a Material Required for Internal Radiation Therapy Called TAT
Helping to expedite the commercialization of a type of radiation therapy that is effective against cancer which has spread widely through bodyTOKYO, Oct 19, 2021 - (JCN Newswire) - Hitachi, Ltd. (TSE:
Sennan Gun Japan General Kumatori Cho Taihaku Ku Usage Research Center Kyoto University Institute For Integrated Radiation
Source: finanznachrichten.de